{
  "resourceType" : "Bundle",
  "id" : "ccrr-content-bundle-example",
  "meta" : {
    "versionId" : "1",
    "lastUpdated" : "2020-11-29T02:03:28.045+00:00",
    "profile" : ["http://hl7.org/fhir/us/central-cancer-registry-reporting/StructureDefinition/ccrr-content-bundle"]
  },
  "type" : "collection",
  "timestamp" : "2020-11-20T11:15:33-10:00",
  "entry" : [{
    "fullUrl" : "http://hl7.org/fhir/us/central-cancer-registry-reporting/Composition/ccrr-composition-content-example",
    "resource" : {
      "resourceType" : "Composition",
      "id" : "ccrr-composition-content-example",
      "meta" : {
        "versionId" : "23",
        "lastUpdated" : "2021-08-19T22:06:32.441+00:00",
        "source" : "#6i8cijintDjJ8In2",
        "profile" : ["http://hl7.org/fhir/us/central-cancer-registry-reporting/StructureDefinition/ccrr-composition"]
      },
      "text" : {
        "status" : "extensions",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b> Amy Shaw data for HCS </b></p></div>"
      },
      "identifier" : {
        "value" : "c03eab8c-11e8-4d0c-ad2a-b385395e27db"
      },
      "status" : "final",
      "type" : {
        "coding" : [{
          "system" : "http://loinc.org",
          "code" : "72134-0"
        }]
      },
      "subject" : {
        "reference" : "Patient/example",
        "display" : "Amy Shaw"
      },
      "encounter" : {
        "reference" : "Encounter/encounter-cancer-example",
        "display" : "Patient encounter procedure"
      },
      "date" : "2023-01-02T22:13:23Z",
      "author" : [{
        "reference" : "Practitioner/1",
        "display" : "Nicholas Joseph"
      }],
      "title" : "Central Cancer Registry Report",
      "section" : [{
        "title" : "Primary Cancer Condition Section",
        "code" : {
          "coding" : [{
            "system" : "http://snomed.info/sct",
            "code" : "363346000",
            "display" : "Malignant neoplastic disease (disorder)"
          }]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Primary Cancer Condition Section</p></div>"
        },
        "entry" : [{
          "reference" : "Condition/primary-cancer-condition-breast"
        }]
      },
      {
        "title" : "Cancer Stage Group section",
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "21908-9",
            "display" : "Stage group.clinical Cancer"
          }]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Cancer Stage Group</p></div>"
        },
        "entry" : [{
          "reference" : "Observation/cancer-stage-group-example"
        }]
      },
      {
        "title" : "Cancer Radio Therapy Course Summary section",
        "code" : {
          "coding" : [{
            "system" : "http://snomed.info/sct",
            "code" : "1217123003",
            "display" : "Radiotherapy course of treatment"
          }]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Cancer Radio Therapy Course Summary</p></div>"
        },
        "entry" : [{
          "reference" : "Procedure/radiotherapy-example"
        }]
      },
      {
        "title" : "Allergies Section",
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "48765-2",
            "display" : "Allergies and adverse reactions Document"
          }]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p>Allergy to Sulfonide</p></div>"
        },
        "entry" : [{
          "reference" : "AllergyIntolerance/example"
        }]
      },
      {
        "title" : "Medications Section",
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "10160-0",
            "display" : "History of Medication use Narrative"
          }]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n Medications section: cancer-related medication </div>"
        },
        "entry" : [{
          "reference" : "MedicationAdministration/cancer-related-medication-admin-example"
        },
        {
          "reference" : "Medication/example"
        }
      ]
      }]
    }
  },
  {
  "fullUrl" : "http://hl7.org/fhir/us/central-cancer-registry-reporting/MedicationAdministration/cancer-related-medication-admin-example",
  "resource" : {
    "resourceType" : "MedicationAdministration",
    "id" : "cancer-related-medication-admin-example",
    "meta" : {
      "profile" : ["http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"]
    },
    "text" : {
      "status" : "extensions",
      "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b><a name=\"cancer-related-medication-admin-cyclophosphamide-jenny-m\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration &quot;cancer-related-medication-admin-cyclophosphamide-jenny-m&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mcode-cancer-related-medication-administration.html\">Cancer-Related Medication Administration Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#373808002)</span></p><p><b>status</b>: completed</p><p><b>category</b>: Outpatient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-medicationrequest-category.html\">MedicationRequest Category Codes</a>#outpatient)</span></p><p><b>medication</b>: cyclophosphamide <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#3002)</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-jenny-m.html\">Patient/cancer-patient-jenny-m</a> &quot; M&quot;</p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Actor</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Practitioner-us-core-practitioner-nancy-oncology-nurse.html\">Practitioner/us-core-practitioner-nancy-oncology-nurse</a> &quot; NURSE&quot;</td></tr></table><p><b>reasonReference</b>: <a href=\"Condition-primary-cancer-condition-jenny-m.html\">Condition/primary-cancer-condition-jenny-m</a></p><p><b>note</b>: cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style=\"display: none\">*</td><td>Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></td><td>932.59 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>"
    },
    "extension" : [{
      "url" : "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "http://snomed.info/sct",
          "code" : "373808002",
          "display" : "Curative - procedure intent (qualifier value)"
        }]
      }
    }],
    "status" : "completed",
    "category" : {
      "coding" : [{
        "system" : "http://terminology.hl7.org/CodeSystem/medicationrequest-category",
        "code" : "outpatient"
      }]
    },
    "medicationCodeableConcept" : {
      "coding" : [{
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "3002",
        "display" : "cyclophosphamide"
      }]
    },
    "subject" : {
      "reference" : "Patient/cancer-patient-jenny-m"
    },
    "effectiveDateTime" : "2018-04-22",
    "performer" : [{
      "actor" : {
        "reference" : "Practitioner/us-core-practitioner-nancy-oncology-nurse"
      }
    }],
    "reasonReference" : [{
      "reference" : "Condition/primary-cancer-condition-jenny-m"
    }],
    "note" : [{
      "authorReference" : {
        "reference" : "Practitioner/us-core-practitioner-nancy-oncology-nurse"
      },
      "time" : "2018-04-22",
      "text" : "cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."
    }],
    "dosage" : {
      "route" : {
        "coding" : [{
          "system" : "http://snomed.info/sct",
          "code" : "47625008",
          "display" : "Intravenous route (qualifier value)"
        }]
      },
      "dose" : {
        "value" : 932.59,
        "unit" : "mg",
        "system" : "http://unitsofmeasure.org",
        "code" : "mg"
      }
    }
  }
},
  {
    "fullUrl" : "http://hl7.org/fhir/us/central-cancer-registry-reporting/Medication/example",
    "resource" : {
      "resourceType": "Medication",
      "id": "example",
      "meta": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/instance-name",
            "valueString": "Uscore Med1 Example"
          },
          {
            "url": "http://hl7.org/fhir/StructureDefinition/instance-description",
            "valueMarkdown": "This is a uscore med1 example for the *US Core Medication Profile*."
          }
        ],
        "profile": [
          "http://hl7.org/fhir/us/core/StructureDefinition/us-core-medication"
        ]
      },
      "text": {
        "status": "generated",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"uscore-med1\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-us-core-medication.html\">US Core Medication Profile</a></p></div><p><b>code</b>: lisinopril oral 10 mg <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#206765 \"Prinivil 10 MG Oral Tablet\")</span></p></div>"
      },
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "206765",
            "display": "Prinivil 10 MG Oral Tablet"
          }
        ],
        "text": "lisinopril oral 10 mg"
      }
    }
  }]
}